Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study. (Q52591611)
Jump to navigation
Jump to search
scientific article published on 9 April 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study. |
scientific article published on 9 April 2018 |
Statements
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study (English)
Pierre Fenaux
Mark Litzow
Thomas Cluzeau
Norbert Vey
Rami S Komrokji
Thomas Prebet
Mikkael A Sekeres
Pau Montesinos
Maximilian Stahl
Nikolai A Podoltsev
Aref Al-Kali
Valeria Santini
Gail J Roboz
Sarah Perreault
Josefina Serrano
Michelle DeVeaux
Ellen K Ritchie
Navneet Majhail
John Barnard
Amir T Fathi
Tae Kon Kim
Vivek Verma
Guido Kobbe
Juan Bergua
Steven D Gore